www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Links  |  Webmaster 
Updated Sun, August 22, 2010.
451.www.afa.asso.fr3210
452.www.maitrise-orthop.com3170
453.www.medicina.unige.it3080
454.www.masef.com3060
455.www.implantecoclear.org3040
456.www.pathologie-online.de3010
457.www.fsm.it3010
458.www.atemwegsliga.de2990
459.www.inrca.it2940
460.www.carnetpsy.com2890
461.edumed.unige.ch2870
462.www.drg.de2850
463.www.donorvoorlichting.nl2820
464.www.mipediatra.com.mx2800
465.www.microbes-edu.org2790
466.www.abio.org2790
467.www.medweb.nl2750
468.www.nuklearmedizin.de2740
469.www.scamilloforlanini.rm.it2740
470.www.mednet.nl2740
471.minf.vub.ac.be2740
472.www.medizin-mainz.de2730
473.www.chirurgie.de2710
474.www.fondazionesanraffaele.it2670
475.www.impp.de2660
476.www.huderf.be2660
477.www.abilify.com2640
478.www.imbi.uni-freiburg.de2620
479.www.med.tu-muenchen.de2600
480.www.droit-medical.net2590
481.www.bdc.de2580
482.www.aromasin.com2570
483.www.prostata.de2550
484.www.chusa.jussieu.fr2550
485.www.harmoclin.com2540
486.www.medmix.at2530
487.www.sigg.it2530
488.www.beroepsziekten.nl2530
489.www.ao-siena.toscana.it2520
490.www.dokter.nl2510
491.www.zol.be2500
492.www.plastische-chirurgie.de2490
493.www.avisveneto.it2490
494.www.endojournals.org2460
495.www.ecr.org2460
496.www.bdh.de2460
497.www.hepatoweb.com2460
498.www.lareb.nl2460
499.www.medizin-websites.de2420
500.www.atih.sante.fr2420
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 



Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Newsvine

486. www.medmix.at

Rating: 2530 points*
*amount mentions of word 'www.medmix.at' on the other websites

www.medmix.at

medmix.at Das innovative Info-Magazin für Mediziner

Description: medmix.at - Das innovative Info-Magazin für Mediziner

Most popular searches: www.medix.at, wwwmedmix.at, vaccines, wwwmedmix.at, www.medmix.ta, Cardiac, Nachrichten, www.edmix.at, www.medmixa.t, doctor, physician, medicine, www.medmx.at, www.medmix.a, www.medmix.t, www.medimx.at, medical information, medical research, blood pressure, Immunology, www.medmix.at, www.memix.at, asthma, Krankenhaus, www.emdmix.at, ww.medmix.at, www.memdix.at, cholesterol, ww.medmix.at, drug, www.mdmix.at, wwwm.edmix.at, family practice, health care, patient, Pharmaceutical, www.medmi.xat, www.medmi.at, Allergy, obesity, health, genome, drug rehab, www.mdemix.at, www.medmxi.at, www.medmixat, ww.wmedmix.at, www.medmix.at

Google

© 2005-2010 www.Top100Medicine.com
Rutgers plans Camden campus nursing school
Rutgers University Wednesday announced plans for a School of Nursing at its Camden Campus.
feeds.bizjournals.com
Sell Genzyme Near Term Due to Continued Manufacturing Challenges
Yesterday, Genzyme (GENZ) provided a manufacturing update with regard to the production of its blockbuster drug Cerezyme, and Fabrazyme - treatments for Gaucher disease and Fabry disease, respectively. The company reiterated that the it has sanitized and restarted the bioreactors that produce both drugs. Importantly, Cerezyme remains on track for shipment in Q4/09. However, Fabrazyme shipments are expected to be delayed until mid-December. The reasons for this latest setback are two-fold. The Fabrazyme bioreactors were the last to be sanitized and ultimately restarted for production; and The Fabrazyme bioreactors are not producing as much product as they were before the Allston plant was shut-down for cleansing. Based on these challenges, the company has revised its FY2009 revenue guidance for Fabrazyme to $450 million from a previous range of $510 to $520 million. Cerezyme revenues were guided to come in at approximately $800 million for FY2009, which compares to the company's previous guidance for the lower end of between $750 million to $1 billion.Complete Story »
seekingalpha.com
ERT Reports Third Quarter 2009 Results (PR Newswire)
eResearchTechnology, Inc. , , a leading provider of centralized ECG, ePRO and other services to the biopharmaceutical, medical device and related industries, announced today results for the third quarter and nine-month period ended September 30, 2009.
us.rd.yahoo.com
Medicare's Rules Pinching Patients
New Medicare payment rules that limit reimbursements for home-oxygen therapy have created hardships for some patients and medical suppliers.
online.wsj.com
NeoStem: BioInsurance for the Future
M.E. Garza submits: When Robin L. Smith M.D., Chairman of the Board and Chief Executive Officer of NeoStem Inc. (AMEX:NBS) first got involved with the company three years ago, it was a four cent stock called “Phase III Medical.” The company was making investments in companies for pieces of royalties and revenues. To its credit, one of the companies Phase III was very interested in helping finance was a tiny company called NeoStem. Now, as the science of stem cells continues to advance, doctors have come to realize that in each of us, stem cells become less and less in quantity and quality. This is cue not only to aging, but also to our environment, the food we eat and various other health factors.Complete Story »
seekingalpha.com